Please login to the form below

Not currently logged in
Email:
Password:

Aspen Global Incorporated

This page shows the latest Aspen Global Incorporated news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca sells rights to seven anaesthetics in $770m deal

AstraZeneca sells rights to seven anaesthetics in $770m deal

AstraZeneca sells rights to seven anaesthetics in $770m deal. Ten-year agreement with Aspen continues the streamlining of its operations. ... AstraZeneca has divested seven drugs from its anaesthetics portfolio through a $770m deal with Aspen Global

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics